| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Saitama Cancer Center Research Institute, Saitama 362-0806, Japan
The study on incorporation of [3H](-)-epigallocatechin gallate (EGCG) into human lung cancer cell line PC-9 indicated that the [3H]EGCG incorporation was significantly enhanced by (-)-epicatechin, an inert tea polyphenol without a galloyl moiety. (-)-Epicatechin enhanced apoptosis, growth inhibition of PC-9 cells, and inhibition of tumor necrosis factor-
release from BALB/c-3T3 cells by EGCG and other tea polyphenols with a galloyl moiety in a dose-dependent manner. Moreover, the effects of EGCG on induction of apoptosis were also synergistically enhanced by other cancer-preventive agents, such as sulindac and tamoxifen. This paper reports significant evidence that whole green tea is a more reasonable mixture of tea polyphenols for cancer prevention in humans than EGCG alone and that it is even more effective when it is used in combination with other cancer preventives.
This article has been cited by other articles:
![]() |
C. D. Davis Nutritional Interactions: Credentialing of Molecular Targets for Cancer Prevention Experimental Biology and Medicine, February 1, 2007; 232(2): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Dashwood Frontiers in Polyphenols and Cancer Prevention J. Nutr., January 1, 2007; 137(1): 267S - 269S. [Full Text] [PDF] |
||||
![]() |
M. R. Sartippour, R. Pietras, D. C. Marquez-Garban, H.-W. Chen, D. Heber, S. M. Henning, G. Sartippour, L. Zhang, M. Lu, O. Weinberg, et al. The combination of green tea and tamoxifen is effective against breast cancer Carcinogenesis, December 1, 2006; 27(12): 2424 - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guo, J. Lu, A. Subramanian, and G. E. Sonenshein Microarray-Assisted Pathway Analysis Identifies Mitogen-Activated Protein Kinase Signaling as a Mediator of Resistance to the Green Tea Polyphenol Epigallocatechin 3-Gallate in Her-2/neu-Overexpressing Breast Cancer Cells. Cancer Res., May 15, 2006; 66(10): 5322 - 5329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lev-Ari, L. Strier, D. Kazanov, L. Madar-Shapiro, H. Dvory-Sobol, I. Pinchuk, B. Marian, D. Lichtenberg, and N. Arber Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells Clin. Cancer Res., September 15, 2005; 11(18): 6738 - 6744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-E. Huh, E.-O. Lee, M.-S. Kim, K.-S. Kang, C.-H. Kim, B.-C. Cha, Y.-J. Surh, and S.-H. Kim Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways Carcinogenesis, August 1, 2005; 26(8): 1436 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Qanungo, M. Das, S. Haldar, and A. Basu Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells Carcinogenesis, May 1, 2005; 26(5): 958 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimizu, A. Deguchi, J. T.E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein (-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells Clin. Cancer Res., April 1, 2005; 11(7): 2735 - 2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ardies Inflammation as Cause for Scar Cancers of the Lung Integr Cancer Ther, September 1, 2003; 2(3): 238 - 246. [Abstract] [PDF] |
||||
![]() |
S. Hsu, W. B. Bollag, J. Lewis, Q. Huang, B. Singh, M. Sharawy, T. Yamamoto, and G. Schuster Green Tea Polyphenols Induce Differentiation and Proliferation in Epidermal Keratinocytes J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Orner, W.-M. Dashwood, C. A. Blum, G. D. Diaz, Q. Li, and R. H. Dashwood Suppression of tumorigenesis in the Apcmin mouse: down-regulation of {beta}-catenin signaling by a combination of tea plus sulindac Carcinogenesis, February 1, 2003; 24(2): 263 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, X. Yang, H. Jiao, and B. Zhao Tea Catechins Protect against Lead-Induced Cytotoxicity, Lipid Peroxidation, and Membrane Fluidity in HepG2 Cells Toxicol. Sci., September 1, 2002; 69(1): 149 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, C. W. Binns, and A. H. Lee Tea Consumption and Ovarian Cancer Risk: A Case-Control Study in China Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 713 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yang, H. S. Oz, S. Barve, W. J. S. de Villiers, C. J. McClain, and G. W. Varilek The Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate Blocks Nuclear Factor-kappa B Activation by Inhibiting Ikappa B Kinase Activity in the Intestinal Epithelial Cell Line IEC-6 Mol. Pharmacol., September 1, 2001; 60(3): 528 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Yang, J. Y. Chung, G.-y. Yang, S. K. Chhabra, and M.-J. Lee Tea and Tea Polyphenols in Cancer Prevention J. Nutr., February 1, 2000; 130(2): 472 - 472. [Abstract] [Full Text] |
||||
![]() |
T. E. Crew, D. J.E. Elder, and C. Paraskeva A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate Carcinogenesis, January 1, 2000; 21(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |